Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

31 Mar 20264 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology, Volume 44, Issue 14 , Page 1379-1379, May 2026.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 31 Mar 2026. The item focuses on Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. Open the detail page to review the full original feed content.